RT Book, Section A1 Bauer, Larry A. A2 Bauer, Larry A. SR Print(0) ID 3520010 T1 Chapter 8. Procainamide/N-Acetyl Procainamide T2 Applied Clinical Pharmacokinetics, 2e YR 2008 FD 2008 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-147628-7 LK accesspharmacy.mhmedical.com/content.aspx?aid=3520010 RD 2024/03/28 AB Procainamide is an antiarrhythmic agent that is used intravenously and orally. It is classified as a type IA antiarrhythmic agent and can be used for the treatment of supraventricular or ventricular arrhythmias.1,2 It is a drug of choice for the treatment of stable sustained monomorphic ventricular tachycardia.3 Procainamide is a useful agent in the treatment of idiopathic repetitive polymorphic ventricular tachycardia in patients with coronary heart disease. It can also be used to treat incessant or recurrent polymorphic ventricular tachycardia secondary to acute myocardial ischemia after revasculariztion has been performed and β-blockers have been administered.3